24/7 eTV BreakingNews Show : Danna maɓallin ƙara (hagu na hagu na allon bidiyo)
Danna nan idan wannan shine sakin labaran ku!

Shugabannin Novavax zuwa Majalisar Tallafin Duniya ta Turai

Written by edita

Kamfanin Biotechnology Novavax, Inc. wanda aka sadaukar da shi don haɓakawa da tallata allurar rigakafin ƙarni na gaba don cututtuka masu saurin kamuwa da cuta, a yau ya sanar da cewa Vivek Shinde, MD, Mataimakin Shugaban ƙasa, Ci gaban Clinical, zai gabatar da gabatarwa yayin Babban Taron Duniya na Turai 2021.

Print Friendly, PDF & Email

Taken tattaunawa zai kasance Novavax 'COVID-NanoFlu V Combination Vaccine, wanda ya haɗu da kamfanin recombinant nanoparticle protein-based protein-based COVID-19 da NanoFlu candidates' yan takarar allurar rigakafi tare da Matrix-M ™ adjuvant a cikin tsari guda.       

Bayanin zaman kamar haka:

Rana: Laraba, 20 ga Oktoba, 2021
Lokaci: 11:30 na safe - 12:00 na yamma Lokacin Tsakiyar Turai (CET) /
 
5:30 na safe - 6:00 na yamma Lokacin Hasken Rana na Gabas (EDT)
Taken: Sabunta kan allurar Novavax 'NanoFlu da haɓaka allurar rigakafin COVID-19-NanoFlu
Mahalarta Novavax: Vivek Shinde, MD, Mataimakin Shugaban ƙasa, Ci gaban Magunguna
 
 

Dandalin fasahar recombinant na kamfani yana haɗa ƙarfi da saurin injiniyan kwayoyin halitta don samar da ingantattun samfuran nanoparticles waɗanda aka tsara don magance buƙatun lafiyar duniya na gaggawa. Novavax yana gudanar da gwajin asibiti na ƙarshen-lokaci don NVX-CoV2373, ɗan takarar rigakafin cutar kan SARS-CoV-2, kwayar cutar da ke haifar da COVID-19. NanoFlu ™, allurar rigakafin cutar nanoparticle ta huɗu, ta sadu da duk maƙasudi na farko a cikin mahimmancin gwajin asibiti na 3 a cikin tsofaffi. Duka 'yan takarar allurar rigakafin sun hada da Novavax' Matrix-M ™ na saponin na saponin don inganta martanin rigakafi da kuma tayar da manyan matakan rigakafin garkuwar jiki.

Print Friendly, PDF & Email

Game da marubucin

edita

Babban edita shine Linda Hohnholz.

Leave a Comment